Back
Forte Biosciences Vs. Corcept Therapeutics Industry Stock Comparison
Sell
36
FBRX
Forte Biosciences
Last Price:
$6.43
Seasonality Move:
-11.18%
Buy
59
CORT
Corcept Therapeutics
Last Price:
$71.72
Seasonality Move:
7.25%
Sell
36
Forte Biosciences (FBRX)
is a Sell
Is Forte Biosciences a Buy, Sell or Hold?
-
The current Forte Biosciences [FBRX] share price is $6.71. The Score for FBRX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
FBRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
-
The current Corcept Therapeutics [CORT] share price is $71.71. The Score for CORT is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
CORT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FBRX Stock Price Chart
What is Forte Biosciences's stock price today?
-
The Forte Biosciences share price today is $6.71Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FBRX is experiencing slight buying pressure.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $71.71Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing slight buying pressure.
FBRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.28 | Sell |
Relative Strength Index (14 RSI): | 48.51 | Sell |
Chaikin Money Flow: | 12642 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.8 - 7.78) | Sell |
Bollinger Bands (100): | (6.56 - 19.6) | Sell |
CORT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 8 | Buy |
Relative Strength Index (14 RSI): | 53.82 | Buy |
Chaikin Money Flow: | 248801 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (57.39 - 82.39) | Buy |
Bollinger Bands (100): | (52.05 - 71.21) | Buy |
FBRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.75 | Sell |
20-day SMA: | 6.53 | Buy |
50-day SMA: | 7.45 | Sell |
200-day SMA: | 10.81 | Sell |
8-day EMA: | 6.63 | Buy |
20-day EMA: | 6.68 | Buy |
50-day EMA: | 8.08 | Sell |
200-day EMA: | 11.48 | Sell |
CORT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 67.1 | Buy |
20-day SMA: | 72.85 | Sell |
50-day SMA: | 65.66 | Buy |
200-day SMA: | 51.54 | Buy |
8-day EMA: | 68.74 | Buy |
20-day EMA: | 64.17 | Buy |
50-day EMA: | 44.97 | Buy |
200-day EMA: | 15.91 | Buy |
Forte Biosciences Earnings Growth & FBRX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $6.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $8.32 per share, and an increase next year of $1.35 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.29 per share, and an increase next year of $1.64 per share.
Forte Biosciences Technical Analysis
Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Corcept Therapeutics Technical Analysis
Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |